biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > What Types of News Are Possible?

<< Previous

Bullboard Posts

Next >>

Comment by KayakerBCon Dec 10, 2022 10:42pm

107 Views

Post# 35164353

RE:RE:RE:RE:RE:RE:What Types of News Are Possible?

KFC, do what you want with them.

Beenthere, if I wanted more shares I would have bought at 0.165 on Friday when the big sell order hit. I wouldn't wait so I could buy from you for 0.20. Really I wouldn't.

Perhaps engage and focus a few more brain cells on this (I think they might be firing randomly). Why would Dr Dr be flying around Canada in the winter and why would they be "signaling" to shareholders that they should attend the meeting if it was going to be a nothing-burger?

<< Previous

Bullboard Posts

Next >>

Dollar Tree CEO Rick Dreiling steps down as discount retailer struggles